SlideShare una empresa de Scribd logo
1 de 38
Raj Kiran Medapalli, MD, MPH.  Nephrology Fellow January 5 th  2011 Mount Sinai School of Medicine Division of Nephrology Journal Club
Transplant Nephrectomy Improves Survival following a Failed Renal Allograft . JASN 21: 374–380, 2010. Journal Club  January 5 th  2011 Raj Kiran Medapalli, MD, MPH.
Failed renal allograft - Disease burden ,[object Object],[object Object],[object Object]
Prognosis after failed primary renal allograft ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Death after primary renal allograft loss 78564 pts who underwent primary renal transplant  between 1988-1998; 10 yr follow-up. USRDS In comparison, annual death rate on renal transplant waiting list is  6.33% per 100-pt-years (9.27% for diabetics) Annual adjusted death rates per 100 pt-years Death with functioning transplant Death after graft loss N Annual rate % N Annual rate % Overall 10816 2.81 4712 9.42 Cardio-vasc 3402 0.69 2252 4.31 Infectious 1856 0.37 879 1.63 Malignancy 808 0.19 122 0.11
Source: Kaplan and Meier-Kriesche. AJT 2002; 2: 970-74
Potential explanations for high mortality in patients with allograft failure ,[object Object],[object Object],[object Object]
Allograft nephrectomy after transplant failure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Allograft nephrectomy after transplant failure (US)
Allograft nephrectomy & repeat transplantation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Usual indications for transplant nephrectomy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Withdrawal of immunosuppression after allograft failure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Study Design - 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
Study Design - 2 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Study outcomes & Statistical analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Propensity Scores ,[object Object],[object Object],[object Object],[object Object]
Propensity Scores ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Propensity Scores ,[object Object],[object Object],[object Object],[object Object],[object Object]
Results ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
b Defined as need for dialysis before hospital discharge after transplantation.
 
d Coded during any hospitalization occurring after return to dialysis after failed kidney transplant.
 
Unadjusted Rates (1994-2004) All-cause mortality Total N=10,951 32 vs. 36 per 100 Person Years (p=0.0324) Repeat transplantation Total N=10,951  10% vs. 4.1% (p<0.001)
Adjusted for : ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adjusted rates + Sensitivity Analysis
Results summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Study strengths ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Study weaknesses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
My Conclusions - 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],My Conclusions - 2
My conclusions - 3 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]

Más contenido relacionado

La actualidad más candente

No evidence of ccsvi in multiple sclerosis
No evidence of ccsvi in multiple sclerosisNo evidence of ccsvi in multiple sclerosis
No evidence of ccsvi in multiple sclerosisuvcd
 
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal AllocationJose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocationincucai_isodp
 
Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017CHAKEN MANIYAN
 
Journal club SMART trial NEJM
Journal club  SMART trial NEJM Journal club  SMART trial NEJM
Journal club SMART trial NEJM CHAKEN MANIYAN
 
4 5764843123465258464
4 57648431234652584644 5764843123465258464
4 5764843123465258464amarewoldie1
 
Preparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistanPreparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistanDr. Muhammad Saifullah
 
Evaluation of kidney donor sudan 2017
Evaluation of kidney donor sudan 2017Evaluation of kidney donor sudan 2017
Evaluation of kidney donor sudan 2017FarragBahbah
 
Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....
Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....
Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....Brussels Heart Center
 
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...Scintica Instrumentation
 
Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017 Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017 CHAKEN MANIYAN
 
Transcatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forTranscatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forHans Garcia
 
Basics of immunosuppression in kidney transplantation
Basics of immunosuppression in kidney transplantationBasics of immunosuppression in kidney transplantation
Basics of immunosuppression in kidney transplantationFarragBahbah
 
Treatment and early outcome of 11 children with hepatoblastoma.
Treatment and early outcome of 11 children with hepatoblastoma.Treatment and early outcome of 11 children with hepatoblastoma.
Treatment and early outcome of 11 children with hepatoblastoma.Dr./ Ihab Samy
 
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...Maarten Naesens
 
Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.Vishal Golay
 
Management of Renal Transplant Patients
Management of Renal Transplant PatientsManagement of Renal Transplant Patients
Management of Renal Transplant Patientsdrsanjaymaitra
 

La actualidad más candente (20)

No evidence of ccsvi in multiple sclerosis
No evidence of ccsvi in multiple sclerosisNo evidence of ccsvi in multiple sclerosis
No evidence of ccsvi in multiple sclerosis
 
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal AllocationJose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
 
Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017Journal club NEJM kidney transplantation IDES 2017
Journal club NEJM kidney transplantation IDES 2017
 
Journal club SMART trial NEJM
Journal club  SMART trial NEJM Journal club  SMART trial NEJM
Journal club SMART trial NEJM
 
4 5764843123465258464
4 57648431234652584644 5764843123465258464
4 5764843123465258464
 
Preparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistanPreparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistan
 
Evaluation of kidney donor sudan 2017
Evaluation of kidney donor sudan 2017Evaluation of kidney donor sudan 2017
Evaluation of kidney donor sudan 2017
 
Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....
Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....
Traitement de la FA vu par le chirurgien cardiaque : state of the art. (Dr J....
 
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
 
Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017 Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017
 
Transcatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forTranscatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa for
 
Basics of immunosuppression in kidney transplantation
Basics of immunosuppression in kidney transplantationBasics of immunosuppression in kidney transplantation
Basics of immunosuppression in kidney transplantation
 
Treatment and early outcome of 11 children with hepatoblastoma.
Treatment and early outcome of 11 children with hepatoblastoma.Treatment and early outcome of 11 children with hepatoblastoma.
Treatment and early outcome of 11 children with hepatoblastoma.
 
Kidney Donor evaluation
Kidney Donor evaluationKidney Donor evaluation
Kidney Donor evaluation
 
Lack of evidence in carotid stenosis
Lack of evidence in carotid stenosisLack of evidence in carotid stenosis
Lack of evidence in carotid stenosis
 
Enigma trial
Enigma trialEnigma trial
Enigma trial
 
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
 
Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.
 
Renal transplantation ROX
Renal transplantation ROXRenal transplantation ROX
Renal transplantation ROX
 
Management of Renal Transplant Patients
Management of Renal Transplant PatientsManagement of Renal Transplant Patients
Management of Renal Transplant Patients
 

Similar a Transplant Nephrectomy Improves Survival following a Failed Renal Allograft (Journal Club)

Overview of kidney transplant
Overview of kidney transplantOverview of kidney transplant
Overview of kidney transplantDr. Lalit Agarwal
 
Banff 2011 liver transplant pathology summary session
Banff 2011 liver transplant pathology summary sessionBanff 2011 liver transplant pathology summary session
Banff 2011 liver transplant pathology summary sessionKim Solez ,
 
Cardiovascular risk evaluation and management before renal transplantation sl...
Cardiovascular risk evaluation and management before renal transplantation sl...Cardiovascular risk evaluation and management before renal transplantation sl...
Cardiovascular risk evaluation and management before renal transplantation sl...Christos Argyropoulos
 
RENAL TRANSPLANTATION AN OVERVIEW.ppt
RENAL TRANSPLANTATION AN OVERVIEW.pptRENAL TRANSPLANTATION AN OVERVIEW.ppt
RENAL TRANSPLANTATION AN OVERVIEW.pptLolakshiBR
 
Carotid revascularization in cad patients
Carotid revascularization in cad patientsCarotid revascularization in cad patients
Carotid revascularization in cad patientsDIPAK PATADE
 
Seminar on treatment of renal artery stenosis
Seminar on treatment of renal artery stenosisSeminar on treatment of renal artery stenosis
Seminar on treatment of renal artery stenosisAbid_Kuchay
 
11 surgical bleeding and transfusions
11 surgical bleeding and transfusions11 surgical bleeding and transfusions
11 surgical bleeding and transfusionsDang Thanh Tuan
 
DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)PRAVEEN GUPTA
 
Membranous Nephropathy
Membranous NephropathyMembranous Nephropathy
Membranous Nephropathyedwinchowyw
 
Recurrent glomerulonephritis after kidney transplantation
Recurrent glomerulonephritis after kidney transplantationRecurrent glomerulonephritis after kidney transplantation
Recurrent glomerulonephritis after kidney transplantationscienthiasanjeevani1
 
Pancreas transplantation
Pancreas transplantationPancreas transplantation
Pancreas transplantationOther Mother
 
kidney Transplant in lupus nephritis
kidney Transplant in lupus nephritiskidney Transplant in lupus nephritis
kidney Transplant in lupus nephritisPediatric Nephrology
 

Similar a Transplant Nephrectomy Improves Survival following a Failed Renal Allograft (Journal Club) (20)

Overview of kidney transplant
Overview of kidney transplantOverview of kidney transplant
Overview of kidney transplant
 
Banff 2011 liver transplant pathology summary session
Banff 2011 liver transplant pathology summary sessionBanff 2011 liver transplant pathology summary session
Banff 2011 liver transplant pathology summary session
 
Cardiovascular risk evaluation and management before renal transplantation sl...
Cardiovascular risk evaluation and management before renal transplantation sl...Cardiovascular risk evaluation and management before renal transplantation sl...
Cardiovascular risk evaluation and management before renal transplantation sl...
 
RENAL TRANSPLANTATION AN OVERVIEW.ppt
RENAL TRANSPLANTATION AN OVERVIEW.pptRENAL TRANSPLANTATION AN OVERVIEW.ppt
RENAL TRANSPLANTATION AN OVERVIEW.ppt
 
Renal transplantation
Renal transplantationRenal transplantation
Renal transplantation
 
Carotid revascularization in cad patients
Carotid revascularization in cad patientsCarotid revascularization in cad patients
Carotid revascularization in cad patients
 
Seminar on treatment of renal artery stenosis
Seminar on treatment of renal artery stenosisSeminar on treatment of renal artery stenosis
Seminar on treatment of renal artery stenosis
 
11 surgical bleeding and transfusions
11 surgical bleeding and transfusions11 surgical bleeding and transfusions
11 surgical bleeding and transfusions
 
Emergency cabg .pptx
Emergency cabg .pptxEmergency cabg .pptx
Emergency cabg .pptx
 
DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)
 
Membranous Nephropathy
Membranous NephropathyMembranous Nephropathy
Membranous Nephropathy
 
Recurrent glomerulonephritis after kidney transplantation
Recurrent glomerulonephritis after kidney transplantationRecurrent glomerulonephritis after kidney transplantation
Recurrent glomerulonephritis after kidney transplantation
 
Pancreas transplantation
Pancreas transplantationPancreas transplantation
Pancreas transplantation
 
Dr sudhir vydehi final
Dr sudhir vydehi finalDr sudhir vydehi final
Dr sudhir vydehi final
 
kidney Transplant in lupus nephritis
kidney Transplant in lupus nephritiskidney Transplant in lupus nephritis
kidney Transplant in lupus nephritis
 
Aki cticu final
Aki cticu finalAki cticu final
Aki cticu final
 
Acute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery PatientAcute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery Patient
 
Articulo arritmia
Articulo arritmiaArticulo arritmia
Articulo arritmia
 
Cytoreductive nephrectomy
Cytoreductive nephrectomyCytoreductive nephrectomy
Cytoreductive nephrectomy
 
Management of interstitial fibrosis and tubular atrophy
Management of interstitial fibrosis and tubular atrophyManagement of interstitial fibrosis and tubular atrophy
Management of interstitial fibrosis and tubular atrophy
 

Último

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 

Último (20)

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 

Transplant Nephrectomy Improves Survival following a Failed Renal Allograft (Journal Club)

  • 1. Raj Kiran Medapalli, MD, MPH. Nephrology Fellow January 5 th 2011 Mount Sinai School of Medicine Division of Nephrology Journal Club
  • 2. Transplant Nephrectomy Improves Survival following a Failed Renal Allograft . JASN 21: 374–380, 2010. Journal Club January 5 th 2011 Raj Kiran Medapalli, MD, MPH.
  • 3.
  • 4.
  • 5. Death after primary renal allograft loss 78564 pts who underwent primary renal transplant between 1988-1998; 10 yr follow-up. USRDS In comparison, annual death rate on renal transplant waiting list is 6.33% per 100-pt-years (9.27% for diabetics) Annual adjusted death rates per 100 pt-years Death with functioning transplant Death after graft loss N Annual rate % N Annual rate % Overall 10816 2.81 4712 9.42 Cardio-vasc 3402 0.69 2252 4.31 Infectious 1856 0.37 879 1.63 Malignancy 808 0.19 122 0.11
  • 6. Source: Kaplan and Meier-Kriesche. AJT 2002; 2: 970-74
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.  
  • 14.
  • 15.  
  • 16.  
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.  
  • 24.  
  • 25. b Defined as need for dialysis before hospital discharge after transplantation.
  • 26.  
  • 27. d Coded during any hospitalization occurring after return to dialysis after failed kidney transplant.
  • 28.  
  • 29. Unadjusted Rates (1994-2004) All-cause mortality Total N=10,951 32 vs. 36 per 100 Person Years (p=0.0324) Repeat transplantation Total N=10,951 10% vs. 4.1% (p<0.001)
  • 30.
  • 31. Adjusted rates + Sensitivity Analysis
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.